BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF
申请人:Bayer Pharma Aktiengesellschaft
公开号:US20170020875A1
公开(公告)日:2017-01-26
The present application relates to novel bicyclically substituted uracil derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases.